bivalent vaccines (National Institute Of Allergy and Infectious Diseases/Thomas Jefferson University)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namebivalent vaccines (National Institute Of Allergy and Infectious Diseases/Thomas Jefferson University)
Drug Alias NameBNSPdeltaG-GPBNSP333-GPINAC-BNSP333-GP
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRabiesHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRabiesHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A